(2025). Hypo-Fractionation Radiotherapy in Breast Cancer Patients: Review Article. The Egyptian Journal of Hospital Medicine, 98(1), 706-712. doi: 10.21608/ejhm.2025.410682
. "Hypo-Fractionation Radiotherapy in Breast Cancer Patients: Review Article". The Egyptian Journal of Hospital Medicine, 98, 1, 2025, 706-712. doi: 10.21608/ejhm.2025.410682
(2025). 'Hypo-Fractionation Radiotherapy in Breast Cancer Patients: Review Article', The Egyptian Journal of Hospital Medicine, 98(1), pp. 706-712. doi: 10.21608/ejhm.2025.410682
Hypo-Fractionation Radiotherapy in Breast Cancer Patients: Review Article. The Egyptian Journal of Hospital Medicine, 2025; 98(1): 706-712. doi: 10.21608/ejhm.2025.410682
Hypo-Fractionation Radiotherapy in Breast Cancer Patients: Review Article
In breast carcinoma management, radiation therapy (RT) is a necessary management. The typical therapeutic regimen for RT to the breast involves administering 25 fractions of 2.0 Gy per day over a five-week period. Breast cancer is more suitable for greater fraction sizes than squamous carcinomas, according to datasupporting the use of fewer fractions of more than 2 Gy per day (hypo-fractionation). Consequently, it may exhibit similarly high fractionation sensitivity to the dose-limiting normal tissues, such as muscle, subcutaneous tissues, skin, and ribs. This article examins the literature that supports the hypo-fractionated radiation efficacy in breast cancer treatment, explore the radiobiological rationale that is unique to carcinomas of breast, and present a case for the regimen implementation of shorter, hypo-fractionated RT sessions when radiation administered on breast.
View on SCiNiTO
Top